PD-Inhibitor Nivolumab and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]

Brief Summary

Type:
Kidney

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT03793166

Study #:
STUDY00144538

Start Date:
Oct 31, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03793166

View Complete Trial Details & Eligibility at ClinicalTrials.gov